1. The Effect of Hemoadsorption with CytoSorb on Severe COVID-19 Complications
- Author
-
A. S. Rybalko, S. N. Galkina, A. S. Saryglar, A. V. Voronin, M. I. Rezyapova, N. I. Chaus, S. N. Perekhodov, and N. A. Karpun
- Subjects
hemoadsorption ,hemoperfusion ,cytosorb ,covid-19 ,cytokines ,hyperimmune response ,inflammatory response ,cytokine storm ,multiorgan failure ,respiratory failure ,Medical emergencies. Critical care. Intensive care. First aid ,RC86-88.9 - Abstract
The aim of the study was to assess the effect of hemoadsorption with CytoSorb on the inflammatory response, respiratory failure, and mortality in patients with severe novel coronavirus infection.Materials and methods. A retrospective single-center cohort comparative study of hemoadsorbtion using the CytoSorb therapy included data from 124 COVID-19 ICU patients. Patients were divided into two groups: the study arm with hemoadsorption (group 1, N=93) and the control arm without hemoadsorption (group 2, N=31). Patients in group 1 had more severe respiratory failure at baseline, but were otherwise comparable to patients in group 2 in terms of clinical and demographic parameters.Results. After hemoadsorption, group 1 patients showed significant improvement in 9 of 13 monitored clinical, instrumental, and laboratory parameters: fever (P=0.005), lactate dehydrogenase (LDH) (P
- Published
- 2024
- Full Text
- View/download PDF